The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Open accessAbstract
Despite extensive effort on studying inflammatory processes in the CNS of Parkinson's disease (PD) patients, implications of peripheral monocytes are still poorly understood. Here, we set out to obtain a comprehensive picture of circulating myeloid cells in PD patients. We applied a human primary monocyte culture system and flow cytometry-based techniques to determine the state of monocytes from PD patients during disease. We found that the classical monocytes are enriched in the blood of PD patients along with an increase in the monocyte-recruiting chemoattractant protein CCL2. Moreover, we found that monocytes from PD patients display a pathological hyperactivity in response to LPS stimulation that correlates with disease severity. Inflammatory pre-conditioning was also reflected on the transcriptome in PD monocytes using next-generation sequencing. Further, we identified the CD95/CD95L as a key regulator for the PD-associated alteration of circulating monocytes. Pharmacological neutralization of CD95L reverses the dysregulation of monocytic subpopulations in favor of non-classical monocytes. Our results suggest that PD monocytes are in an inflammatory predisposition responding with hyperactivation to a "second hit". These results provide the first direct evidence that circulating human peripheral blood monocytes are altered in terms of their function and composition in PD patients. This study provides insights into monocyte biology in PD and establishes a basis for future studies on peripheral inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, it has now been well demonstrated in models of severe trauma or advanced disease states that BM-derived monocytes traffic to and influence inflammatory signaling in the brain (Zhou et al, 2009;Grozdanov et al, 2014).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Grozdanov et al, 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · cited 1×
“To assess the progression of PD in patients, the modified Hoehn & Yahr staging system was used [29].”
MethodBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,504
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Nomenclature of monocytes and dendritic cells in blood
Ziegler‐Heitbrock, L., Ancuța, P., Crowe, S. M., Dalod, M., Grau, V., Hart, D. N. J., Leenen, P. J. M., Liu, Y.-J., MacPherson, G. G., Randolph, G. J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-258558 · Cited by 2,436
Genesis: cluster analysis of microarray data
Sturn, A., Quackenbush, J., & Trajanoski, Z. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.1.207 · Cited by 1,761
Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,745
Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,658
Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors
Cros, J. F., Cagnard, N., Woollard, K. J., Patey, N., Zhang, S., Sénéchal, B., Puel, A., Biswas, S. K., Moshous, D., Pïcard, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.012 · Cited by 1,320
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–296 of 296
Rademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 8
Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
Zhao, R., Jia, N., Wu, S., Wen, J., Huang, Y., Zhao, C., & Chen, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141814 · Cited by 7
Mamais, A., Wallings, R. L., & Rocha, E. M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00009-6 · Cited by 6
Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson’s disease
Wang, Y., Zhou, M., Wang, Y., Jiang, D., & Deng, X. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02072-2 · Cited by 6
Obeagu, E. I., & Obeagu, G. U. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004021 · Cited by 5
Chen, H., Xie, W., Chang, Z., Zhang, J., & Xie, D. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00481.2023 · Cited by 5
Kim, J.-B., Kim, Y., Kim, S., Ha, T., Kim, D., Kim, D. W., So, M. L., Kim, S. H., Woo, H. G., Yoon, D., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03041-7 · Cited by 6
Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
Ganguly, U., Singh, S., Chakrabarti, S., Saini, A. K., & Saini, R. V. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.11.010 · Cited by 6
Dhankhar, J., Agrawal, N., & Shrivastava, A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577801 · Cited by 5
Hughes, L. P., Wallings, R. L., Agin‐Liebes, J., Alcalay, R. N., Garrido, A., Tansey, M. G., & Dzamko, N. L. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01185-8 · Cited by 4
Guan, Y., Zhao, C., Zou, H., Yan, X., Luo, L., Wu, J., Li, X., & Zhang, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9670 · Cited by 4
Peripheral immune cell traits and Parkinson’s disease: A Mendelian randomization study
Tian, J., Zuo, C., Shi, J., Ma, D., & Shi, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299026 · Cited by 4
Causal role of myeloid cells in Parkinson’s disease: Mendelian randomization study
Quan, W., Qin, Y., Li, J., Wang, L., Song, J., Xu, J., & Chen, J. (2024) · Inflammation Research · doi:10.1007/s00011-024-01867-8 · Cited by 4
Xi, J., Tang, C., Xiao, X., Chen, M., Zou, Q., & Zhou, X. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03379-24 · Cited by 3
Mark, J. R., Staley, H. A., Titus, A. M., Agin‐Liebes, J., Garrido, A., Hughes, L. P., Dzamko, N. L., Wallings, R. L., & Tansey, M. G. (2025) · Movement Disorders · doi:10.1002/mds.70123 · Cited by 3
Wójcik, P., Culmsee, C., & Adamczyk, A. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01733-7 · Cited by 3
Wang, C., Tang, Y., Yang, T., Wang, Y., Niu, Z., Zhang, K., Lin, N., & Li, Q. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.16665 · Cited by 4
Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity
Peters, R. J., & Stevenson, M. (2022) · Journal of Virology · doi:10.1128/jvi.00484-22 · Cited by 3
Jin, H., Wang, L., Shen, Y., Mao, C., Chen, J., & Liu, C. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002397 · Cited by 3
Artelsmair, M., Miranda-Azpiazu, P., Kingston, L. P., Bergare, J., Schou, M., Varrone, A., & Elmore, C. S. (2019) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3731 · Cited by 4
Investigating lymphocyte populations in patients with Parkinson’s disease
Dzamko, N. L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.29 · Cited by 2
Georgoula, M., Ntavaroukas, P., Campbell, B. J., & Papoutsopoulou, S. (2024) · Epigenetics Reports · doi:10.1080/28361512.2024.2401340 · Cited by 2
Rijal, R., & Gomer, R. H. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02163-25 · Cited by 2
Alborghetti, M., Moliterni, C., Bianchini, E., Rinaldi, D., Caissutti, D., Capozzi, A., Radicati, F. G., Moschillo, A., Marino, M., Berardelli, I., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1761550 · Cited by 2
Bezrukova, A. I., Basharova, K. S., Kopytova, A. E., Nikolaev, M. A., Miliukhina, I. V., Zakharova, E. Y., Pchelina, S., & Usenko, T. S. (2026) · Human Gene · doi:10.1016/j.humgen.2026.201551 · Cited by 2
Castegna, A., Laera, L., Moda, P., Miglietta, S., D’Agostino, M., Ruggiero, M., Cianciulli, A., Filannino, F. M., Porro, C., Butterfield, D. A., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08102-4 · Cited by 3
Scafidi, A., Kaoma, T., Cerella, C., Campus, E., Grzyb, K., Nosirov, B., Mogensen, F. L., Klein, E., Costa, R. D., Skupin, A., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03964-3 · Cited by 2
Profiling peripheral immune cells in Parkinson's disease: A scoping review
Recinto, S. J., Jernigan, J. E., Lefter, N., Vitic, Z., Overgaard, M. O., Liu, L., Howden, A. J. M., Eyer, K., Romero‐Ramos, M., Tansey, M. G., et al. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261479505 · Cited by 2
Neuroinflammation and Immune Dysfunction in the Mechanisms of Development of Parkinson’s Disease
Idova, G. V., Лазаревна, А. Е., & Zhanaeva, S. Y. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01549-8 · Cited by 2
Bianchetti, M. E., Ferreira, A. F. F., & Britto, L. R. (2024) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1511951 · Cited by 2
Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's disease
Ruf, W. P., Palmer, A., Dörfer, L., Wiesner, D., Buck, E., Grozdanov, V., Kassubek, J., Dimou, L., Ludolph, A. C., Huber-Lang, M. S., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105877 · Cited by 2
Self-citationDisease mechanisms as subtypes: Immune dysfunction in Parkinson's disease
Contaldi, E., Magistrelli, L., & Comi, C. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00008-4 · Cited by 3
Biswas, B. K., & Goswami, R. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.100886 · Cited by 2
Shani, S., Gana‐Weisz, M., Bar‐Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., Orr‐Urtreger, A., & Goldstein, O. (2024) · Journal of Parkinson s Disease · doi:10.1177/1877718x241296015 · Cited by 1
Fernández‐Espejo, E., Guerra, M., Castellano, S., de Fonseca, F. R., & de Pablos, Á. M. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70112 · Cited by 1
Afaar, F., Youssef, P., Galper, J., Chua, M., Halliday, G. M., Lewis, S. J. G., & Dzamko, N. L. (2025) · Movement Disorders · doi:10.1002/mds.30233 · Cited by 1
He, Y., Zhang, R., Xie, C., Ji, S., Deng, W., & Teng, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1608631 · Cited by 2
Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease
Camacho, M., Greenland, J. C., Peattie, A. R. D., Spindler, L. R. B., Holbrook, J. A., Kahanawita, L., Fryer, T. D., Hong, Y. T., & Williams‐Gray, C. H. (2025) · Movement Disorders · doi:10.1002/mds.70102 · Cited by 1
Parkinson's disease: A chronic systemic inflammatory disorder
Khan, H., & Benskey, M. J. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00006-3 · Cited by 1
Sebastian-delaCruz, M. (2025) · Advances in genetics · doi:10.1016/bs.adgen.2025.11.010 · Cited by 1
Cell-based immunotherapy for neurodegenerative disease: A promising avenue
Huerta, T. J., Urbina-Muñoz, V., Urra-Alvarez, V., Villablanca, C., Gómez‐Pérez, L. S., Saavedra, B., Contreras, T., & Vidal, R. L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00816 · Cited by 1
Indirubin and Retinoic Acid Show Binding Affinity to Monocyte Biomarker CSF3R in Parkinson's Disease
Bao, Z., Zhi, S., & Jie, M. (2026) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70197 · Cited by 1
Wang, M., Li, T., Liang, K., Chen, Z., Lei, Y., Zhao, J., Tang, X., Xie, Y., Guan, Q., Zhao, X.-F., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116883 · Cited by 1
Su, B., Dong, W., Su, L., Ye, J., Yao, Q., Liu, M., Wu, J., & Du, K. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108344 · Cited by 2
Immune Senescence and Inflammaging in Neurological Diseases
Baden, P., Cicco, S. D., Yu, C., & Deleidi, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_143 · Cited by 1
Changes in the Immune System in Parkinson’s Disease
Romero‐Ramos, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_150-1 · Cited by 1
Parkinson’s Disease in Humans and in Nonhuman Primate Aging and Neurotoxin Models
Metzger, J. M., Jones, C. A., & Emborg, M. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00046-4 · Cited by 1
Chan, A. S.-Y., Han, Y. M. Y., Sze, S. L., Wong, C. K., Chu, I. M., & Cheung, M. (2021) · NeuroSci · doi:10.3390/neurosci2020015 · Cited by 1
NEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE
Idova, G. V., Лазаревна, А. Е., & Zhanaeva, S. Y. (2023) · Журнал высшей нервной деятельности им И П Павлова · doi:10.31857/s0044467723040056 · Cited by 1
Neuroinflammation, glymphatic system, and Parkinson's disease
Saleh, S. M. S., Nasser, N., Tharwat, E. K., Elbehiry, T., & Helmy, H. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00001-3 · Cited by 1
Therapeutic Strategies in Neurodegenerative Diseases
Eid, A. M., Faridar, A., & Appel, S. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_39 · Cited by 1
Immune response during idiopathic Parkinson's disease: From humans to animal models
Nissen, S. K., Ferreira, S. A., Klæstrup, I. H., & Romero‐Ramos, M. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.006 · Cited by 1
Dhankhar, J., Agrawal, N., & Shrivastava, A. (2021) · Preprints.org · doi:10.20944/preprints202109.0277.v1 · Cited by 1
Neuron-derived exosomes trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s diseasePreprint
Chen, Z., Xu, C., Li, G., Wen, Z., Liu, J., & Mao, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-2109216/v1 · Cited by 1
A Parkinson's disease genetic risk score associates with blood DNAm on chromosome 17Preprint
Casazza, W., Schaffner, S., Artaud, F., Domenighetti, C., Schulze-Hentrich, J., Lesage, S., Brice, A., Corvol, J.-C., Mostafavi, S., Kobor, M., et al. (2023) · medRxiv · doi:10.1101/2023.07.21.23293014 · Cited by 1
Bick, R. J., Poindexter, B. J., & Doursout, M. F. (2017) · Journal of Cytokine Biology · doi:10.4172/2576-3881.1000120
Hematological Profile of Patients with Dementia in South Punjab
Khalil, F., Samad, N., Hassan, S., Qureshi, M. A., & Numan, A. (2021) · Pakistan Journal Of Neurological Surgery · doi:10.36552/pjns.v25i2.538
Changes in the Immune System in Parkinson’s Disease
Romero‐Ramos, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_150
Immune Senescence and Inflammaging in Neurological Diseases
Baden, P., Cicco, S. D., Yu, C., & Deleidi, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_143-1
Bezrukova, A. I., Basharova, K. S., Miliukhina, I. V., Timofeeva, A., Senkevich, K. A., Пчелина, С. Н., & Usenko, T. S. (2022) · The Scientific Notes of the Pavlov University · doi:10.24884/1607-4181-2022-29-1-37-45
Sirkis, D. W., Solsberg, C. W., Johnson, T. P., Bonham, L. W., Sturm, V. E., Lee, S. E., Rankin, K. P., Rosen, H. J., Boxer, A. L., Seeley, W. W., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.28.514304
(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00018-6
Liu, Z., Huang, Y. X. R., Wang, X., Li, J., Zhang, C., Yang, Y., & Zhang, J. (2023) · Figshare · doi:10.6084/m9.figshare.22625693
Chen, Z., Li, G., Zhou, L., Zhang, L., You, Y., & Liu, J. (2024) · Research Square · doi:10.1101/2024.05.03.24306837
Epigenetic associations of GPNMB rs199347 variant with alcohol consumption in Parkinson’s disease
Chen, Y., Liaw, Y.-C., Nfor, O. N., Hsiao, C.-H., Zhong, J.-H., Wu, S., & Liaw, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1377403
Crosstalk Between the Immune and Nervous Systems
Vedam‐Mai, V. (2024) · Neuromethods · doi:10.1007/978-1-0716-4083-8_3
Shen, Z., Zhang, J., Jing, X., & Tao, E. (2025) · Parkinson s Disease · doi:10.1155/padi/2323585
Shaw, A. M., Jiménez, V., Nguyen, B., Duvernay, J. B., Choi, S. G., Cameron, M., Killinger, B. A., & Gupta, V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.11.669712
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508692
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508698
Rydbirk, R., Folke, J., Busato, F., Roché, E., Chauhan, A. S., Løkkegaard, A., Hejl, A.-M., Bode, M., Blaabjerg, M., Møller, M. L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11960322
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508689
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508695
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508683
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508701
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508686
Joers, V. L., Murray, B. C., McLaughlin, C., Oliver, D. L., Staley, H. E., Coronado, J., Achat‐Mendes, C., Golshani, S., Kelly, S. D., Goodson, M. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123857
Rydbirk, R., Folke, J., Busato, F., Roché, E., Chauhan, A. S., Løkkegaard, A., Hejl, A.-M., Bode, M., Blaabjerg, M., Møller, M. L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11960316
Liu, Z., Huang, Y. Z., Wang, X., Li, J., Zhang, C., Yang, Y., & Zhang, J. (2023) · Figshare · doi:10.6084/m9.figshare.22625690
Riboldi, G. M., Vialle, R. A., Navarro, E., Udine, E., de Paiva Lopes, K., Humphrey, J., Allan, A., Parks, M., Henderson, B., Astudillo, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20508680
Proteasome Dysregulation in Parkinson’s Disease: Insights from Blood-Based Analyses
Costanzo, A. D., Fusco, C., Camerlingo, R., Serafini, S., Minó, A., Tiberio, C., Palmieri, G., Matrone, C., Cocca, E., & Angiolillo, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05624-8
Epigenetic Signatures in an Italian Cohort of Parkinson’s Disease Patients from Sicily
Salluzzo, M. G., Ferraresi, F., Marcolungo, L., Pirazzini, C., Kwiatkowska, K. M., Dall’Olio, D., Castellani, G., Sala, C., Zago, E. D., Gentilini, D., et al. (2025) · Brain Sciences · doi:10.3390/brainsci16010031
Scafidi, A., Kaoma, T., Cerella, C., Campus, E., Grzyb, K., Nosirov, B., Mogensen, F. L., Klein, E., Costa, R. D., Skupin, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.06.697857
Recinto, S. J., MacDonald, A., Premachandran, S., Liu, L., Bayati, A., Rodriguez, L., Nguyen, M., Petit, F., Mukherjee, S., Larmanjat, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.07.694713
Fernández‐Espejo, E., & de Fonseca, F. R. (2026) · Antioxidants · doi:10.3390/antiox15020201
Peripheral immune profiling in frontotemporal dementia
Gamez, N., Eid, A. M., Pascual, B., Li, D., Wang, Y., Masdeu, J. C., Appel, S. H., & Faridar, A. (2026) · Brain Communications · doi:10.1093/braincomms/fcag089
Understanding the role of perivascular macrophages in Parkinson's disease pathophysiology
Fuentealba, J. R. (2017) · theses.fr (ABES) · doi:10.70675/b2e8f905z4f72z497eza017zc5b9d7fe53a1
Salmani, M., Rastegari‐Pouyani, M., Afshar, S., Ghane, E. T., & Eftekharian, M. M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11709-x
Neuroinflammation and vaccination strategy in Parkinson’s disease
Yukti, Sharma, S., Dubey, A. K., Sharma, A., & Prajapati, V. K. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.04.006
Micro- and nanoplastics as environmental modifiers of neuroimmune dysfunction in Parkinson’s disease
Qian, S., Gao, F., & Wang, P. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1886999
Purkayastha, K., Roy, A., Bhattacharya, P., & Borah, A. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130989
Progress in blood-derived biomarkers for Parkinson’s disease
Mishra, A. K., & Kumar, D. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.001
RNA interference in neurological disorders: Silencing harmful immune responses
Farhan, M., Islam, M. S., Srivastava, Y., Singh, J., Khan, H., & Zhang, Q. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44631-3.00013-5
Li, X., Wang, Q., Min, G., Yuan, X., & Tian, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1759121
Kahveci, O., Ay, U., & Gurvit, H. I. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2026-0155
Groenewald, K., Klein, J. C., Fryer, T. D., Smith, G., Dzamko, N., Chua, M., Scott, A. M., Baskar, J., Hamprecht, D. W., Everett, J., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1951452
Metadata
- Authors
- Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martin-Villalba, A., Hengerer, B., Kassubek, J., Ludolph, A. C., Weishaupt, J. H., & Danzer, K. M.
- Affiliations
- Universität Ulm (DE)
- Boehringer Ingelheim (Germany) (DE)
- Corresponding author
- Danzer, Karin M.
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2014-10-05
- Volume
- 128
- Issue
- 5
- Pages
- 651-663
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4201759
- OpenAlex
- W2003612310
- Cited by
- 295
- References
- 44
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 38 · 2023: 23 · 2022: 37 · 2021: 40 · 2020: 26 · 2019: 19 · 2018: 18 · 2017: 18 · 2016: 13 · 2015: 9
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Fondation Charcot
- Universität Ulm
- Medizinische Fakultät, Universität Ulm
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, peripheral blood monocytes, classical monocytes, MCP-1, lipopolysaccharide response, non-classical monocytes, peripheral inflammation, monocyte transcriptome, disease severity
- MeSH terms
- Cells, Cultured, Culture Media, Female, Flow Cytometry, Humans, Inflammation, Lipopolysaccharides, Male, Monocytes, Parkinson Disease, Phagocytosis, Psychiatric Status Rating Scales, RNA, Messenger, Cohort Studies, Antigens, CD, Interleukin-6, Cytokines, Chemokine CCL2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
